Edition:
India

Aptose Biosciences Inc (APTO.OQ)

APTO.OQ on NASDAQ Stock Exchange Capital Market

6.43USD
12:24am IST
Change (% chg)

$0.55 (+9.27%)
Prev Close
$5.88
Open
$5.87
Day's High
$6.65
Day's Low
$5.80
Volume
167,395
Avg. Vol
135,662
52-wk High
$6.65
52-wk Low
$1.58

Latest Key Developments (Source: Significant Developments)

Aptose Announces Pricing Of Public Offering Of Common Shares
Tuesday, 17 Dec 2019 

Dec 17 (Reuters) - Aptose Biosciences Inc ::APTOSE ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON SHARES.SAYS PUBLIC OFFERING OF 16.1 MILLION COMMON SHARES PRICED AT $4.00PER SHARE.PRICED ITS PREVIOUSLY ANNOUNCED UNDERWRITTEN PUBLIC OFFERING OF 16.1 MILLION COMMON SHARES AT A PRICE OF US$4.00 PER SHARE.  Full Article

Aptose Announces Proposed Public Offering Of Common Shares
Tuesday, 17 Dec 2019 

Dec 16 (Reuters) - Aptose Biosciences Inc ::APTOSE ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES.APTOSE BIOSCIENCES - INTENDS TO USE ALL OR PORTION OF NET PROCEEDS TO ACCELERATE AND EXPAND CLINICAL TRIALS FOR CG-806.APTOSE BIOSCIENCES - ALSO INTENDS TO USE ALL OR PORTION OF NET PROCEEDS TO ACCELERATE AND EXPAND CLINICAL TRIALS FOR APTO-253, AMONG OTHERS.  Full Article

Aptose Biosciences Reports Qtrly Loss Per Share $0.12
Wednesday, 6 Nov 2019 

Nov 5 (Reuters) - Aptose Biosciences Inc ::APTOSE REPORTS RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2019.QTRLY LOSS PER SHARE $0.12.TOTAL CASH AND CASH EQUIVALENTS AND INVESTMENTS AS OF SEPTEMBER 30, 2019 WERE $30.2 MILLION.Q3 EARNINGS PER SHARE VIEW $-0.12 -- REFINITIV IBES DATA.  Full Article

Aptose Biosciences Reports Qtrly Net Loss Per Share Of $0.13
Wednesday, 7 Aug 2019 

Aug 6 (Reuters) - Aptose Biosciences Inc ::APTOSE REPORTS RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2019.APTOSE BIOSCIENCES INC QTRLY NET LOSS PER SHARE $0.13.APTOSE - CASH ON HAND, COMMITTED CAPITAL PROVIDE CO SUFFICIENT RESOURCES TO FUND ALL PLANNED OPERATIONS INCLUDING RESEARCH AND DEVELOPMENT INTO 2H 2020.  Full Article

Aptose Biosciences Files For Mixed Shelf Offering For Up To $100 Mln
Saturday, 27 Apr 2019 

April 26 (Reuters) - Aptose Biosciences Inc ::APTOSE BIOSCIENCES FILES FOR MIXED SHELF OFFERING FOR UP TO $100 MILLION.  Full Article

Aptose Qtrly Loss Per Share $0.16
Wednesday, 7 Nov 2018 

Nov 6 (Reuters) - Aptose Biosciences Inc ::APTOSE REPORTS RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2018.APTOSE BIOSCIENCES INC QTRLY LOSS PER SHARE $0.16.APTOSE BIOSCIENCES INC - TOTAL CASH & CASH EQUIVALENTS & INVESTMENTS AS OF SEPTEMBER 30, 2018 WERE $15.6 MILLION.  Full Article

Aptose Reports Q1 Loss Per Share $0.23
Friday, 11 May 2018 

May 10 (Reuters) - Aptose Biosciences Inc ::APTOSE REPORTS RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2018.Q1 LOSS PER SHARE $0.23.  Full Article

Aptose Biosciences Establishes New At-The-Market Facility
Wednesday, 28 Mar 2018 

March 28 (Reuters) - Aptose Biosciences Inc ::APTOSE BIOSCIENCES ESTABLISHES NEW AT-THE-MARKET FACILITY.APTOSE BIOSCIENCES INC SAYS ENTERED INTO AN "AT-THE-MARKET" SALES AGREEMENT WITH CANTOR FITZGERALD & CO.APTOSE BIOSCIENCES - AS PER SALES AGREEMENT, CO MAY, FROM TIME TO TIME, ISSUE & SELL THROUGH CANTOR, ACTING AS SOLE AGENT, COMMON SHARES OF CO.APTOSE BIOSCIENCES INC - NEW AT-THE-MARKET FACILITY REPLACES PREVIOUS ATM THAT EXPIRED IN DECEMBER 2017.  Full Article

Aptose Reports Qtrly Loss Of $0.12‍​ Per Share
Wednesday, 28 Mar 2018 

March 27 (Reuters) - Aptose Biosciences Inc ::APTOSE REPORTS RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2017.APTOSE BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.12‍​.APTOSE BIOSCIENCES - ‍TOTAL CASH AND CASH EQUIVALENTS AND INVESTMENTS AS OF DEC 31, 2017 WERE $11.4 MILLION​.APTOSE BIOSCIENCES - ‍BASED ON CURRENT ESTIMATIONS, CO HAS SUFFICIENT RESOURCES TO FUND RESEARCH, DEVELOPMENT AND OPERATIONS INTO Q1 2019​.  Full Article

Aptose Biosciences Inc Files For Stock Shelf Of Upto $100 Mln
Thursday, 8 Feb 2018 

Feb 7 (Reuters) - Aptose Biosciences Inc ::APTOSE BIOSCIENCES INC FILES FOR STOCK SHELF OF UPTO $100 MILLION - SEC FILING.  Full Article